Related references
Note: Only part of the references are listed.Thrombosis in patients with myeloma treated in the Myeloma IX and Myeloma XI phase 3 randomized controlled trials
Charlotte A. Bradbury et al.
BLOOD (2020)
Rivaroxaban for Thromboprophylaxis in High-Risk Ambulatory Patients with Cancer
A. A. Khorana et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Derivation and Validation of a Risk Assessment Model for Immunomodulatory Drug-Associated Thrombosis Among Patients With Multiple Myeloma
Ang Li et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2019)
Predicting venous thromboembolism in multiple myeloma: development and validation of the IMPEDE VTE score
Kristen M. Sanfilippo et al.
AMERICAN JOURNAL OF HEMATOLOGY (2019)
Direct oral anticoagulant for the prevention of thrombosis in ambulatory patients with cancer: A systematic review and meta-analysis
Ang Li et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2019)
The Khorana score for prediction of venous thromboembolism in cancer patients: a systematic review and meta-analysis
Frits I. Mulder et al.
HAEMATOLOGICA (2019)
Apixaban to Prevent Venous Thromboembolism in Patients with Cancer
Marc Carrier et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Incidence of skeletal-related events among multiple myeloma patients in the United States at oncology clinics: Observations from real-world data
Christopher Kim et al.
JOURNAL OF BONE ONCOLOGY (2019)
A clinical prediction model for cancer-associated venous thromboembolism: a development and validation study in two independent prospective cohorts
Ingrid Pabinger et al.
LANCET HAEMATOLOGY (2018)
Cancer-Associated Venous Thromboembolic Disease, Version 2.2018 Featured Updates to the NCCN Guidelines
Michael B. Streiff et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2018)
Improving accuracy of International Classification of Diseases codes for venous thromboembolism in administrative data
Kristen M. Sanfilippo et al.
THROMBOSIS RESEARCH (2015)
Venous Thromboembolic Disease Clinical Practice Guidelines in Oncology
Michael B. Streiff et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2013)
Prevention of VTE in Nonsurgical Patients Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines
Susan R. Kahn et al.
CHEST (2012)
Thrombosis is associated with inferior survival in multiple myeloma
Sigurdur Y. Kristinsson et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2012)
Effects of zoledronic acid versus clodronic acid on skeletal morbidity in patients with newly diagnosed multiple myeloma (MRC Myeloma IX): secondary outcomes from a randomised controlled trial
Gareth J. Morgan et al.
LANCET ONCOLOGY (2011)
Arterial and venous thrombosis in monoclonal gammopathy of undetermined significance and multiple myeloma: a population-based study
Sigurdur Y. Kristinsson et al.
BLOOD (2010)
Lenalidomide and high-dose dexamethasone compared with dexamethasone as initial therapy for multiple myeloma: a randomized Southwest Oncology Group trial (S0232)
Jeffrey A. Zonder et al.
BLOOD (2010)
Prediction of venous thromboembolism in cancer patients
Cihan Ay et al.
BLOOD (2010)
Deep vein thrombosis after monoclonal gammopathy of undetermined significance and multiple myeloma
Sigurdur Y. Kristinsson et al.
BLOOD (2008)
Development and validation of a predictive model for chemotherapy-associated thrombosis
Alok A. Khorana et al.
BLOOD (2008)
Prevention of thalidomide- and lenalidomide-associated thrombosis in myeloma
A. Palumbo et al.
LEUKEMIA (2008)
Long-term outcome results of the first tandem autotransplant trial for multiple myeloma
Bart Barlogie et al.
BRITISH JOURNAL OF HAEMATOLOGY (2006)
Malignancies, prothrombotic mutations, and the risk of venous thrombosis
JW Blom et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Review of 1027 patients with newly diagnosed multiple myeloma
RA Kyle et al.
MAYO CLINIC PROCEEDINGS (2003)
Share Paper
